Inchcape PLC (INCH)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 638.00 |
|---|---|
| 52-week range | 604.50 – 895.00 |
| Return, 1 month / 3 months | −17.1% / −21.4% |
| Return, 1 year / 3 years | −13.2% / +8.7% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 26.2% |
| Worst drawdown (1 year) | -26.8% |
| Average daily value traded | 734.90M GBX |
| Dividend yield | 5.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Inchcape PLC is an automotive distribution and retail company based in London. It distributes new and used vehicles for vehicle manufacturers in a range of markets, and it operates dealerships that sell cars and provide servicing, parts and aftersales support to retail and fleet customers. The company also offers financing and insurance products alongside vehicle sales, and it works with manufacturers to develop their brands and dealer networks in the countries where it operates.
On this site Inchcape PLC appears as a stock on the London Stock Exchange (UK), code INCH, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Inchcape PLC (INCH) trades on the London Stock Exchange in UK. It last closed at GBX 638.00 on 27 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a fair price profile), ranking 2,032 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.2% and over the last three months it fell 21.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -18.8% | ||
| From 52-week high | -28.3% | ||
| Momentum | 28 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -21.4% | ||
| 6-month return | -18.2% | ||
| 12-month return, skipping the last month | 4.8% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.8% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 734.90M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −6.4% |
|---|---|
| 1 month | −17.1% |
| 3 months | −21.4% |
| 6 months | −18.2% |
| 1 year | −13.2% |
| 3 years | +8.7% |
| 5 years | −3.5% |
Signals
| 50-day / 200-day average | 761.42 / 785.37 |
|---|---|
| Golden / death cross (60 days) | Death, 8 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 25.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Aug 2026 | GBP 0.1080 |
| 7 May 2026 | GBP 0.2280 |
| 7 Aug 2025 | GBP 0.0950 |
| 1 May 2025 | GBP 0.1720 |
| 8 Aug 2024 | GBP 0.1130 |
| 2 May 2024 | GBP 0.2430 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.